31 noticed a positive trend on graft survival at 2 years in a group treated with IVIG/steroids + ATG or Rituximab compared to IVIG/steroids alone.
← all excerpts
Antibody-mediated rejection after kidney transplantation in children; therapy challenges and future potential treatments.
2
—
—
The sentences
However, this observation did not reach statistical significance, likely due to the low number of patients (12/123 patients received ATG and 37/123 received Rituximab).